Real-world performance of myositis antibody panels: a single-centre experience

Marina Dueñas-Ochoa; Roni Meidan; João Francisco Abrantes; Emily Apsley; David Isenberg

doi:10.1093/rheumatology/keag343

June 26, 2026Lara D. VeekenOpen Access

Real-world performance of myositis antibody panels: a single-centre experience

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to assess the real-world effectiveness and performance of myositis antibody panels in clinical settings.
Single-centre evaluation of myositis antibody panels
Analysis of diagnostic performance in patients with myositis
Real-world clinical data collection and assessment
Improved diagnostic accuracy for identifying myositis-related autoantibodies
Increased clinical utility observed in patient management strategies
Enhanced detection rates of specific myositis-associated antibody profiles

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Evaluates diagnostic performance of myositis antibody panels, suggesting improved clinical utility.

Abstract

Marina Dueñas-Ochoa, Roni Meidan, João Francisco Abrantes, Emily Apsley, David Isenberg; Real-world performance of myositis antibody panels: a single-centr

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dueñas-Ochoa et al. (2026) studied this question.

synapsesocial.com/papers/6a40bb4561bb0a67205c6e9f https://doi.org/10.1093/rheumatology/keag343

View Full Paper

Ask AI

Bookmark

Share

Real-world performance of myositis antibody panels: a single-centre experience

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Real-world performance of myositis antibody panels: a single-centre experience

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading